Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.33% | -24.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.84% | -18.56% | |||
| Operating Income | 11.84% | 18.56% | |||
| Income Before Tax | 10.50% | 18.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.50% | 18.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.50% | 18.35% | |||
| EBIT | 11.84% | 18.56% | |||
| EBITDA | 12.96% | 18.36% | |||
| EPS Basic | 61.59% | 28.07% | |||
| Normalized Basic EPS | 62.57% | 28.07% | |||
| EPS Diluted | 61.59% | 28.07% | |||
| Normalized Diluted EPS | 62.57% | 28.07% | |||
| Average Basic Shares Outstanding | 133.05% | 13.49% | |||
| Average Diluted Shares Outstanding | 133.05% | 13.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||